26,777 Shares in Core Laboratories Inc. (NYSE:CLB) Bought by Franklin Resources Inc.

Franklin Resources Inc. purchased a new stake in shares of Core Laboratories Inc. (NYSE:CLB) in the 4th quarter, according to the company in its most recent Form 13F filing with the SEC. The institutional investor purchased 26,777 shares of the oil and gas company’s stock, valued at approximately $464,000. Franklin Resources Inc. owned 0.06% of Core Laboratories as of its most recent SEC filing.

Several other institutional investors have also added to or reduced their stakes in CLB. FMR LLC raised its stake in shares of Core Laboratories by 182.9% during the third quarter. FMR LLC now owns 17,057 shares of the oil and gas company’s stock valued at $316,000 after acquiring an additional 11,028 shares during the last quarter. State Street Corp raised its position in Core Laboratories by 2.9% during the 3rd quarter. State Street Corp now owns 1,975,016 shares of the oil and gas company’s stock valued at $36,597,000 after purchasing an additional 56,187 shares during the last quarter. Jane Street Group LLC lifted its holdings in Core Laboratories by 53.8% in the 3rd quarter. Jane Street Group LLC now owns 71,989 shares of the oil and gas company’s stock worth $1,334,000 after buying an additional 25,189 shares during the period. Barclays PLC grew its position in shares of Core Laboratories by 288.2% in the 3rd quarter. Barclays PLC now owns 83,570 shares of the oil and gas company’s stock worth $1,549,000 after buying an additional 62,042 shares during the last quarter. Finally, Geode Capital Management LLC increased its stake in shares of Core Laboratories by 0.7% during the third quarter. Geode Capital Management LLC now owns 1,053,204 shares of the oil and gas company’s stock valued at $19,521,000 after buying an additional 7,721 shares during the period. Hedge funds and other institutional investors own 97.81% of the company’s stock.

Core Laboratories Trading Up 2.1 %

NYSE CLB opened at $12.58 on Friday. The firm has a market capitalization of $587.28 million, a PE ratio of 19.05, a P/E/G ratio of 0.99 and a beta of 1.99. The stock’s 50 day moving average is $14.63 and its 200 day moving average is $17.49. Core Laboratories Inc. has a twelve month low of $10.14 and a twelve month high of $25.13. The company has a quick ratio of 1.71, a current ratio of 2.32 and a debt-to-equity ratio of 0.49.

Core Laboratories (NYSE:CLB) last announced its earnings results on Wednesday, January 29th. The oil and gas company reported $0.23 EPS for the quarter, meeting analysts’ consensus estimates of $0.23. Core Laboratories had a net margin of 5.99% and a return on equity of 16.24%. Research analysts forecast that Core Laboratories Inc. will post 0.96 earnings per share for the current fiscal year.

Core Laboratories Announces Dividend

The business also recently disclosed a quarterly dividend, which was paid on Monday, March 3rd. Investors of record on Monday, February 10th were given a dividend of $0.01 per share. This represents a $0.04 dividend on an annualized basis and a yield of 0.32%. The ex-dividend date of this dividend was Monday, February 10th. Core Laboratories’s dividend payout ratio (DPR) is presently 6.06%.

Analyst Ratings Changes

CLB has been the subject of a number of research analyst reports. Stifel Nicolaus dropped their price target on Core Laboratories from $19.00 to $15.00 and set a “hold” rating for the company in a research note on Tuesday. Citigroup raised shares of Core Laboratories from a “sell” rating to a “neutral” rating and raised their target price for the stock from $15.00 to $16.00 in a research report on Wednesday, March 12th. One investment analyst has rated the stock with a sell rating and four have assigned a hold rating to the stock. According to data from MarketBeat, the stock has a consensus rating of “Hold” and a consensus target price of $15.75.

About Core Laboratories

Core Laboratories Inc provides reservoir description and production enhancement services and products to the oil and gas industry in the United States, and internationally. It operates through Reservoir Description and Production Enhancement segments. The Reservoir Description segment includes the characterization of petroleum reservoir rock and reservoir fluid samples to enhance production and improve recovery of crude oil and gas from its clients' reservoirs.